BASF: Analyst Targets Stretch 14 Euros Apart as Geopolitical Risks Split Views
Published on 07/17/2026 at 19:01 | Redaktion boerse-global.de
The chemical giant BASF finds itself caught between bullish and bearish analyst camps, with price targets ranging from €47 to €61 — a spread of roughly 30% of the current share price. The divergence reflects deeper uncertainty about whether the company’s recent earnings momentum is sustainable or merely a product of temporary tailwinds.
Shares traded at €48.62 late Thursday, about 12% below the 52-week high of €55.05 reached in April. The stock sits just 1.7% above its 200-day moving average of €47.59, suggesting a fragile medium-term uptrend, while trading 2.7% below its 50-day average of €49.71. The relative strength index of 49.2 points to a market that has yet to pick a direction.
A Sector in the Crosshairs
The cautious stance adopted by some analysts reflects broader industry headwinds. Germany’s chemical industry association VCI released disappointing first-half data on Thursday: production fell roughly 3% year-on-year, while sales slipped 1% to €106 billion. VCI President Markus Steilemann described the situation as “a breather, not a turning point,” noting that investment has now declined for three consecutive years.
The VCI attributed a recent uptick in activity largely to one-off factors. Companies restocked inventories amid the Middle East conflict, and competition from Asia eased temporarily due to the closure of the Strait of Hormuz. Still, the association forecasts a 1.5% decline in full-year production.
Should investors sell immediately? Or is it worth buying BASF?
That sector-wide gloom spilled into broader market sentiment after BASF’s mid-week numbers. Shares of Wacker Chemie fell 3.8%, Lanxess dropped 4.2%, Evonik lost 2.8%, and Fuchs slid 2.2%, while BASF itself shed 3.6% during midday trading.
The Two Camps
Private bank Berenberg took a dim view. Analyst Sebastian Bray cut his BASF price target from €52 to €47, maintaining a “Hold” rating. His reasoning: prices for many base chemicals have already returned to levels seen before the Iran conflict, removing a key support. At the same time, disappointing Chinese growth data is shifting investor focus from supply constraints to potential demand weakness in the world’s second-largest economy.
Bernstein Research pushed back, reaffirming a positive stance and a €61 target, citing surprisingly strong second-quarter metrics. Deutsche Bank also remains upbeat on the stock.
The optimists point to BASF’s upgraded 2026 EBITDA guidance to a range of €6.9 billion to €7.7 billion, up from the prior €6.2 billion to €7.0 billion. Second-quarter revenue rose 16% year-on-year to €17.2 billion, while EBITDA before special items hit €2.4 billion — well above the €2.1 billion consensus compiled by Vara Research.
The Strait of Hormus Wild Card
Both sides agree on one thing: the outlook hinges on negotiations between the US and Iran regarding the Strait of Hormuz. BASF itself flagged “considerable uncertainty” linked to this geopolitical variable in its outlook. A lasting reopening of the waterway would support the upper end of the new guidance; a prolonged closure would drag toward the lower end — or worse.
The second-quarter beat came with asterisks. A €3.9 billion gain from the sale of the coatings business to Carlyle distorted net income for the period. Free cash flow turned negative at €0.2 billion, compared with a positive €0.5 billion a year earlier, as higher raw material prices tied up working capital.
BASF at a turning point? This analysis reveals what investors need to know now.
Analysts on the bearish side argue that the headline earnings jump conceals a less convincing core performance. Should the Strait of Hormuz conflict escalate, input costs could rise further and margins come under renewed pressure.
What Comes Next
With the annualized 30-day volatility at 22.39%, traders are bracing for continued swings. The stock is likely to oscillate between its 50-day and 200-day averages until the geopolitical outlook becomes clearer. A diplomatic breakthrough could lift shares toward the 52-week high of €55.05; a worsening conflict would likely extend the recent slide.
The next concrete test arrives on July 29, when BASF publishes its full semi-annual report. Investors will scrutinize whether the second-quarter trends hold up and how explicitly management spells out the risks for the second half. Until then, the €14 gap between analyst targets captures the market’s wait-and-see posture.
Ad
BASF Stock: New Analysis - 17 July
Fresh BASF information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
